Commodore Capital as of March 31, 2024
Portfolio Holdings for Commodore Capital
Commodore Capital holds 39 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 13.1 | $196M | 4.4M | 45.03 | |
| Vera Therapeutics Cl A (VERA) | 9.1 | $137M | 3.2M | 43.12 | |
| Nuvalent Inc-a (NUVL) | 7.5 | $112M | 1.5M | 75.09 | |
| Xenon Pharmaceuticals (XENE) | 6.2 | $93M | 2.2M | 43.05 | |
| Spyre Therapeutics Com New (SYRE) | 4.8 | $72M | 1.9M | 37.93 | |
| Enliven Therapeutics (ELVN) | 4.7 | $70M | 4.0M | 17.59 | |
| Vaxcyte (PCVX) | 3.9 | $59M | 860k | 68.31 | |
| Mind Medicine Mindmed Com New (MNMD) | 3.7 | $55M | 5.8M | 9.40 | |
| Alpine Immune Sciences | 3.6 | $55M | 1.4M | 39.64 | |
| Arvinas Ord (ARVN) | 3.5 | $53M | 1.3M | 41.28 | |
| Rhythm Pharmaceuticals (RYTM) | 3.0 | $46M | 1.1M | 43.33 | |
| Cogent Biosciences (COGT) | 2.9 | $43M | 6.4M | 6.72 | |
| Pharvaris N V (PHVS) | 2.7 | $40M | 1.7M | 23.11 | |
| Celldex Therapeutics Com New (CLDX) | 2.4 | $36M | 867k | 41.97 | |
| Nkarta (NKTX) | 2.3 | $34M | 3.2M | 10.81 | |
| Miragen Therapeutics (VRDN) | 2.3 | $34M | 1.9M | 17.51 | |
| Celcuity (CELC) | 2.2 | $34M | 1.6M | 21.60 | |
| Kura Oncology (KURA) | 2.2 | $33M | 1.5M | 21.33 | |
| C4 Therapeutics Com Stk (CCCC) | 1.9 | $28M | 3.4M | 8.17 | |
| Oric Pharmaceuticals (ORIC) | 1.8 | $28M | 2.0M | 13.75 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.8 | $27M | 1.9M | 14.30 | |
| IsoRay | 1.7 | $25M | 21M | 1.19 | |
| Immunovant (IMVT) | 1.6 | $24M | 751k | 32.31 | |
| Kyverna Therapeutics (KYTX) | 1.5 | $23M | 912k | 24.84 | |
| Engene Holdings (ENGN) | 1.4 | $21M | 1.3M | 16.95 | |
| Apogee Therapeutics (APGE) | 1.3 | $19M | 290k | 66.45 | |
| Cabaletta Bio (CABA) | 1.3 | $19M | 1.1M | 17.06 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.0 | $15M | 2.3M | 6.38 | |
| Third Harmonic Bio (THRD) | 0.8 | $12M | 1.3M | 9.44 | |
| Neurogene (NGNE) | 0.7 | $10M | 200k | 50.90 | |
| Adverum Biotechnologies Com New (ADVM) | 0.6 | $9.3M | 657k | 14.14 | |
| Vistagen Therapeutics Ord (VTGN) | 0.6 | $8.3M | 1.6M | 5.28 | |
| Syndax Pharmaceuticals (SNDX) | 0.5 | $7.6M | 319k | 23.80 | |
| Soleno Therapeutics (SLNO) | 0.5 | $7.3M | 170k | 42.80 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 0.3 | $5.2M | 500k | 10.40 | |
| Macrogenics (MGNX) | 0.3 | $4.3M | 295k | 14.72 | |
| Adicet Bio (ACET) | 0.2 | $3.2M | 1.4M | 2.35 | |
| Sab Biotherapeutics Com New (SABS) | 0.1 | $832k | 183k | 4.54 | |
| Dbv Technologies S A Sponsored Adr | 0.0 | $69k | 93k | 0.75 |
